GlassScriptPhysician profile
Mary Anne Simmonds
NPI 1356333751
$3,601.25
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,713 · 2020: $500 · 2021: $737 · 2022: $430 · 2023: $128 · 2024: $93.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $729.04 | 2019-2021 | |
| Genentech USA, INC. | $558.56 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $475.09 | 2019-2023 | |
| Seagen INC. | $201.23 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $197.70 | 2019-2020 | |
| Gilead Sciences, INC. | $136.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.05 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $107.98 | 2019 | |
| Puma Biotechnology, INC. | $106.11 | 2019 | |
| Eisai INC. | $105.15 | 2019 | |
| Tesaro, INC. | $104.72 | 2019 | |
| Abbvie INC. | $102.22 | 2019 | |
| Lilly USA, LLC | $100.11 | 2019 | |
| Pharmacosmos Therapeutics INC. | $98.07 | 2021 | |
| Daiichi Sankyo INC. | $92.87 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $88.84 | 2021 | |
| Amgen INC. | $83.00 | 2019 | |
| Exelixis INC. | $67.68 | 2021 | |
| Celgene Corporation | $37.13 | 2022 | |
| Merck Sharp & Dohme LLC | $30.38 | 2019-2020 | |
| Eli Lilly and Company | $25.99 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $20.27 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $19.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Simmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.